Bioshares changed their view on avx from buy to lighten when the...

Bioshares changed their view on avx from buy to lighten when the price hit 29c. It soon raced up to over $1.

Then they put out a buy recommendation (I can't recall at what price) & now they say sell again.

I have wondered if to do the opposite to Bioshare's recommendations. They said strong buy on cce at 42c (now 3c) & strong sell on sla at 22c (now $1.17).

re the dosing. It's interesting that despite great results with the current dosage, the fda want other dosage to be tested. That could easily be seen as a good thing. After all they want an increased dosage to be administered!

wait for the current panic to settle, then buy & hold imho